grant
Single cell opioid (fentanyl) responses in the context of HIV
Organization UNIVERSITY OF CINCINNATILocation CINCINNATI, UNITED STATESPosted 15 Jul 2025Deadline 31 Mar 2030
NIHUS FederalResearch GrantFY202621+ years oldAIDS VirusAIDS focused researchAIDS related researchAIDS researchAIDS scienceAIDS specific researchAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusActiqAdultAdult HumanAffectAgeAlcohol Chemical ClassAlcoholsAnti-HIV PositivityApoptosisApoptosis PathwayAreaAtlasesB blood cellsB cellB cellsB-CellsB-LymphocytesB-cellBioinformaticsBlood CellsBlood SampleBlood monocyteBlood specimenCD4 CellsCD4 Positive T LymphocytesCD4 T cellsCD4 helper T cellCD4 lymphocyteCD4+ T-LymphocyteCD4-Positive LymphocytesCD8 CellCD8 T cellsCD8 lymphocyteCD8+ T cellCD8+ T-LymphocyteCD8-Positive LymphocytesCD8-Positive T-LymphocytesCell BodyCell CommunicationCell Communication and SignalingCell InteractionCell SignalingCell-to-Cell InteractionCellsChemotactic CytokinesCocaineCommunitiesCrystal MethCrystal methamphetamineCytotoxic cellDataDendritic CellsDeoxyephedrineDesoxyephedrineDiacetylmorphineDiamorphineDrug PrescribingDrug PrescriptionsDrug usageDrugsDuragesicEnrollmentFatality rateFentanestFentanylFentylFundingGene ExpressionGenesHCVHCV infectionHIVHIV InfectionsHIV PositiveHIV PositivityHIV SeroconversionHIV SeropositivityHIV antibody positiveHIV diagnosisHIV diseaseHIV focused researchHIV individualsHIV infected individualsHIV infected personsHIV investigationHIV peopleHIV positive individualsHIV positive peopleHIV related researchHIV replicationHIV researchHIV scienceHIV specific researchHIV viral infectionHIV viral replicationHIV virus infectionHIV+HIV-1 diseaseHIV-1 infectionHIV-1 replicationHIV-1 viral replicationHIV-1 virus replicationHIV/AIDS diseaseHTLV-III SeroconversionHTLV-III SeropositivityHepatitis C virusHepatitis C virus infectionHepatocarcinogenesisHeroinHomologous Chemotactic CytokinesHuman Immunodeficiency VirusesIFNImmuneImmunesIn VitroInfectionInfection by HIV-1Infection from HIV-1Infection of HIV-1Injecting drug userInjection Drug UserInnate Immune ResponseIntercrinesInterferon Type IInterferonsIntracellular Communication and SignalingInvestigation on HIVK lymphocyteLAV-HTLV-IIILiquid ChromatographyLiver CarcinogenesisLocationLymphadenopathy-Associated VirusMacrophageMarrow monocyteMediatingMedicationMedicineMethamphetamineMethylamphetamineMicroRNAsModelingMorbidityMφN-MethylamphetamineNIDANK CellsNational Institute of Drug AbuseNational Institute on Drug AbuseNatural Killer CellsOhioOpiate ReceptorsOpiatesOpioidOpioid ReceptorOverdosePBMCPLWHPWHPWIDParticipantPathogenesisPathologyPathway interactionsPatientsPeripheralPeripheral Blood CellPeripheral Blood Mononuclear CellPharmaceutical PreparationsPhentanylPopulationPredispositionProgrammed Cell DeathRT-PCRRecreationResearchReverse Transcriptase Polymerase Chain ReactionRiskSIS cytokinesSamplingSignal TransductionSignal Transduction SystemsSignalingSusceptibilityT4 CellsT4 LymphocytesT8 CellsT8 LymphocytesTimeTranslational ResearchTranslational ScienceUniversitiesValidationVeiled CellsViralViral DiseasesViral GenesVirusVirus DiseasesVirus-HIVabused drugabused drugsaddictionaddictive disorderadulthoodagesbiological signal transductioncarcinogenesis in the livercell typechemoattractant cytokinechemokinecohortcollegecollegiatecytokinedifferential expressiondifferentially expresseddrug abuseddrug of abusedrug usedrug/agentdrugs abuseddrugs of abuseenrollexperimentexperimental researchexperimental studyexperimentsfentalogsfentaloguesfentanyl analogfentanyl useglobal gene expressionglobal transcription profilehepatic carcinogenesishepatitis C infectionhepatocellular carcinogenesishuman immunodeficiency virus diseasehuman immunodeficiency virus infectionhuman immunodeficiency virus replicationhuman immunodeficiency virus researchhuman immunodeficiency virus-1 replicationin vivoindividuals infected with HIVindividuals with HIVindividuals with human immunodeficiency virusinfected with HCVinfected with HIVinfected with hepatitis Cinfected with hepatitis C virusinfected with human immunodeficiency virusinfection by hepatitis c virusinfection with HCVinfection with hepatitis Cinfection with hepatitis C virusinjection drug useliver cancer pathogenesisliver tumorigenesismedication prescriptionmethmiRNAmonocytemortalitymultiomicsmultiple omicsnovelopiate consumptionopiate crisisopiate drug useopiate intakeopiate overdoseopiate related overdoseopiate useopioid consumptionopioid crisisopioid drug overdoseopioid drug useopioid epidemicopioid induced overdoseopioid intakeopioid intoxicationopioid medication overdoseopioid overdoseopioid poisoningopioid related overdoseopioid toxicityopioid useoverdose deathoverdose fatalitiespanomicspathwaypeople infected with HIVpeople infected with human immunodeficiency viruspeople living with HIVpeople who inject drugspeople who inject illicit drugspeople with HIVpeople with human immunodeficiency virusperipheral bloodpersons who inject drugsprescribed medicationreceptor expressionresearch addressing HIVresearch in HIVresearch into HIVresearch on HIVresearch on human immunodeficiency virusresearch to address HIVresponsereverse transcriptase PCRscRNA sequencingscRNA-seqscience on HIVscience to address HIVsingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingstudies on HIVsynthetic opiatesynthetic opioidtandem mass spectrometrytherapy optimizationtranscriptional differencestranscriptometranslation researchtranslational investigationtreatment optimizationvalidationsviral infectionvirus infectionvirus-induced disease
Description preview
Abstract
The number of drug overdose deaths has increased significantly in recent years. By 2019, 70.6% of drug
overdose deaths involved opioids, and in Ohio, >90% of unintentional overdose deaths involved fentanyl.
Opioid receptors are expressed in multiple peripheral blood mononuclear cell (PBMC) types that are
susceptible to HIV infection but…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click